REVERSE 5-year follow up: CRT impact persists
Mohamed ElMaghawry1, Mahmoud Farouk1
1Department of Cardiology, Aswan Heart Centre, Kasr ElHajjar, Aswan, Egypt.
Insights
Cardiac resynchronization therapy (CRT) significantly improves outcomes for heart failure patients with mild symptoms. Long-term analysis confirms CRT
Area of Science:
- Cardiology
- Heart Failure Management
- Cardiac Electrophysiology
Background:
- Previous trials (MIRACLE ICD II, MADIT-CRT, RAFT, REVERSE) demonstrated benefits of cardiac resynchronization therapy (CRT) in heart failure (HF) patients with depressed left ventricular ejection fraction (LV EF) and wide QRS.
- Observed benefits include reverse cardiac remodeling and reduced HF adverse events, leading to guideline recommendations for CRT in NYHA Class II patients.
- Further research was recommended to ascertain survival benefits of CRT in mildly symptomatic patients.
Purpose of the Study:
- To present the 5-year analysis of the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) trial.
- To specifically assess the long-term benefits of CRT in patients with mild heart failure symptoms.
Main Methods:
- Prospective, 5-year follow-up study design.
- Inclusion of patients with mild heart failure manifestations, depressed LV EF, and wide QRS complex.
- Analysis of data from the REVERSE trial.
Main Results:
- Consistent observed benefits in reverse cardiac remodeling.
- Reduction in heart failure adverse events.
- Long-term data from the 5-year REVERSE trial analysis published in the European Heart Journal.
Conclusions:
- The 5-year analysis of the REVERSE trial provides further evidence for the long-term benefits of CRT.
- Findings support the use of CRT in selected NYHA Class II heart failure patients.
- Continued investigation into survival benefits is warranted.
Abstract:
The role of cardiac resynchronization therapy (CRT) in patients presenting with mild manifestations of heart failure (HF), depressed left ventricular ejection fraction (LV EF), and wide QRS complex, has been addressed in four previous trials: MIRACLE ICD II,(1) MADIT-CRT,(2) RAFT,(3) and REVERSE.(4) The consistent observed benefits in reverse cardiac remodelling and reduction of heart failure adverse events have resulted in guideline recommendations for CRT in NYHA Class II patients. The guidelines also recommend further studies to determine whether survival is increased by CRT in patients with mild symptoms. The 5-year analysis of the REsynchronization reVErses Remodeling Systolic left vEntricular (REVERSE) trial, which was designed prospectively for 5-year follow-up to specifically assess the long term benefits of CRT, were recently published in the European Heart Journal.(5).
Related Concept Videos
Continuous Renal Replacement Therapy
Electroconvulsive Therapy
Types of Impact
The coefficient of restitution is a metric for understanding the dynamics of impacts. It quantifies the ratio of relative velocity...
Effects of Creep
Traumatic Memory
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy


